Danaher Corp. agreed to buy US medical technology firm Masimo Corp., in a deal with an enterprise value of about $9.9 billion.Danaher will pay $180 per share in cash for Masimo, close to a 40% premium over the closing share price on Friday, according to a statementBloomberg Terminal Tuesday. The transaction is expected to be completed in the second half of the year....